Loading...
Patrys Limited
PAB.AX•ASX
Healthcare
Biotechnology
A$0.002
A$0.00(0.00%)
Patrys Limited (PAB.AX) Financial Performance & Income Statement Overview
Review Patrys Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-51.11%
↓ 51.11%
Operating Income Growth
64.11%
↑ 64.11%
Net Income Growth
49.88%
↑ 49.88%
Operating Cash Flow Growth
68.58%
↑ 68.58%
Operating Margin
-213.54%
↓ 213.54%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-213.54%
↓ 213.54%
ROE
-114.17%
↓ 114.17%
ROIC
-157.22%
↓ 157.22%
Patrys Limited (PAB.AX) Income Statement & Financial Overview
Review Patrys Limited's (PAB.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $724729.00 | $669434.00 | $1.03M | $1.83M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $724729.00 | $669434.00 | $1.03M | $1.83M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $1.55M | $972648.00 | $3.16M | $4.37M |
| SG&A Expenses | $760040.00 | $1.10M | $1.04M | $1.35M |
| Operating Expenses | $2.31M | $2.07M | $4.20M | $5.72M |
| Total Costs & Expenses | $2.31M | $2.07M | $4.20M | $5.72M |
| Interest Income | $48066.00 | $61059.00 | $67737.00 | $9138.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $23503.00 | $23494.00 | $23212.00 | $23775.00 |
| EBITDA | -$1.56M | -$2.01M | -$4.13M | -$5.71M |
| EBITDA Ratio | -$2.16 | -$2.88 | -$3.07 | -$2.12 |
| Operating Income | -$1.59M | -$2.07M | -$4.20M | -$5.72M |
| Operating Income Ratio | -$2.19 | -$3.10 | -$4.09 | -$3.13 |
| Other Income/Expenses (Net) | -$676663.00 | -$61059.00 | $67737.00 | $9136.00 |
| Income Before Tax | -$2.26M | -$2.01M | -$4.13M | -$5.71M |
| Income Before Tax Ratio | -$3.12 | -$3.007 | -$4.03 | -$3.12 |
| Income Tax Expense | -$676663.00 | -$61059.00 | -$958176.00 | -$1.82M |
| Net Income | -$1.59M | -$1.95M | -$3.17M | -$3.89M |
| Net Income Ratio | -$2.19 | -$2.92 | -$3.09 | -$2.13 |
| EPS | -$0.001 | -$0.001 | -$0.002 | -$0.002 |
| Diluted EPS | -$0.001 | -$0.001 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $2.06B | $2.04B | $2.06B | $2.06B |
| Weighted Avg Shares Outstanding (Diluted) | $2.06B | $2.04B | $2.06B | $2.06B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan